Global Diabetes Testing Program Market Growth (Status and Outlook) 2025-2031

The global Diabetes Testing Program market size is predicted to grow from US$ 2450 million in 2025 to US$ 3847 million in 2031; it is expected to grow at a CAGR of 7.8% from 2025 to 2031.

A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.

The Global key players of Diabetes Testing Program include Roche, LifeScan, Abbott Laboratories, etc. The top three players hold a share over 44%. China is the largest market, and has a share about 33%. In terms of product type, HbA1c Test is the largest segment, which occupied for a share of about 66%. For application, Home Test is the largest segment, which has a share about 42%.

LPI (LP Information)' newest research report, the “Diabetes Testing Program Industry Forecast” looks at past sales and reviews total world Diabetes Testing Program sales in 2024, providing a comprehensive analysis by region and market sector of projected Diabetes Testing Program sales for 2025 through 2031. With Diabetes Testing Program sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diabetes Testing Program industry.

This Insight Report provides a comprehensive analysis of the global Diabetes Testing Program landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Diabetes Testing Program portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diabetes Testing Program market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diabetes Testing Program and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diabetes Testing Program.

This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Testing Program market by product type, application, key players and key regions and countries.

Segmentation by Type:

HbA1c Test

Finger-prick Test

Segmentation by Application:

Medical Diagnosis

Home Test

Lab Testing

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Roche

LifeScan

Abbott Laboratories

Ascensia

Arkray

I-SENS

Omron

Braun

Siemens

Bio-Rad Laboratories

Tosoh

Danaher Corporation

Trinity Biotech

HUMAN Diagnostics

Terumo

Sinocare

Acon Biotech

Please note: The report will take approximately 2 business days to prepare and deliver.